DIZBI raises seed funding at Rs 20 crore valuation

DIZBI recently announced the closure of its seed funding round, with a post-money valuation of Rs 20 crore.

Founded in 2024 after being acquired by entrepreneur Suresh Dakavarapu from PDS Group, DIZBI launched its operations to revolutionize traditional medicine by creating a holistic, integrated healthcare platform. The platform connects practitioners with global audiences and offers seamless access to e-pharmacies and diagnostic labs, thereby simplifying patient care.

Purpose of fundraising

The startup plans to use the raised capital to enhance its technological capabilities, expand its reach globally, and strengthen community ties among practitioners and patients.

According to the company's statement, the fresh funds will enable the development of e-labs and expand e-pharmacy offerings to enhance service delivery. Additionally, it will focus on scaling market efforts, building a supportive, knowledgeable community, and launching a comprehensive platform.

Leadership comments

"We are profoundly grateful for the trust our investors, including many from the traditional healthcare community, have placed in us. Their support not only validates our mission but also strengthens our resolve to make traditional healthcare accessible and efficient through technological innovation," said Suresh Dakavarapu, CEO of DIZBI.